Discounted Cash Flow
Xtant Medical Holdings, Inc.
—
—
Average annual growth rates
| Metric | 10-Year | 5-Year | 3-Year |
|---|---|---|---|
| Sales | — | — | — |
| Free Cash Flow | — | — | — |
| Average (FCF & NI) | — | — | — |
| Net Income | — | — | — |
Endpoint CAGR (better for long term trend)
| Metric | 10-Year | 5-Year | 3-Year |
|---|---|---|---|
| Sales | — | — | — |
| Free Cash Flow | — | — | — |
| Average (FCF & NI) | — | — | — |
| Net Income | — | — | — |
Projected growth rate
—
—
%
%
Historical inputs (10 fiscal years)
| YEAR | Sales | Net Income | Free Cash Flow | Net Margin | EPS (diluted) |
|---|---|---|---|---|---|
| 2016 | $90.0m | $-19.5m | $-20.2m | -21.7% | $-1.54 |
| 2017 | $82.6m (-8.2%) | $-52.4m (-168.9%) | $-2.2m (89.2%) | -63.4% (-192.9%) | $-34.76 (-2157.1%) |
| 2018 | $72.2m (-12.6%) | $-70.1m (-33.7%) | $588.0k (126.9%) | -97.1% (-53.0%) | $-5.97 (82.8%) |
| 2019 | $64.7m (-10.4%) | $-8.2m (88.3%) | $-1.3m (-319.7%) | -12.7% (86.9%) | $-0.63 (89.4%) |
| 2020 | $53.3m (-17.5%) | $-7.0m (14.6%) | $-2.3m (-76.2%) | -13.2% (-3.6%) | $-0.25 (60.3%) |
| 2021 | $55.3m (3.6%) | $-4.8m (31.0%) | $-1.7m (26.4%) | -8.8% (33.4%) | $-0.06 (76.0%) |
| 2022 | $58.0m (4.9%) | $-8.5m (-75.0%) | $-7.1m (-323.9%) | -14.6% (-66.8%) | $-0.09 (-50.0%) |
| 2023 | $91.3m (57.5%) | $660.0k (107.8%) | $-11.0m (-54.4%) | 0.7% (104.9%) | $0.01 (111.1%) |
| 2024 | $117.3m (28.4%) | $-16.4m (-2592.3%) | $-16.0m (-45.9%) | -14.0% (-2040.5%) | $-0.12 (-1300.0%) |
| 2025 | $133.9m (14.2%) | $5.0m (130.2%) | $10.2m (163.5%) | 3.7% (126.5%) | $0.04 (133.3%) |
Base FCF: — (latest fiscal year)
Discount rate: % —
Terminal growth: —
Projection period: — years
Alt A decline yrs:
Alt B total yrs:
Projected cash flows
| Year | Projected cash flow | Discount Factor | Present Value |
|---|
PV of projected FCF: —
Terminal FCF: —
Terminal value: —
PV of terminal value: —
Enterprise value (DCF): —
Current price: —
—Alternative DCF Models
| Model | Fair Value | Upside | PV(FCFs) | PV(Terminal) | Total Years |
|---|---|---|---|---|---|
| Standard (10yr→TV) | — | — | — | — | 10 + TV |
| Alt A (Gradual Decline) | — | — | — | — | — |
| Alt B (30yr Hard Stop) | — | — | — | N/A | — |
This is a simplified DCF model for illustration. It uses reported free cash flow, a single growth assumption, fixed WACC, and a Gordon Growth terminal value. It is not investment advice.